Amaero lands A$7.8 million titanium powder deal to bolster FY2027 strategy Proactive uses images sourced from Shutterstock Amaero Ltd (ASX:3DA, OTCQX:AMROF) has signed a supplier agreement that includes a A$7.8 million purchase order for spherical titanium alloy powders, locking in minimum quarterly shipments from July 2026 to June 2027 in a deal that materially strengthens revenue visibility for FY2027 and supports the company’s production growth strategy. The agreement, struck with a private equity-backed manufacturing technology and advanced materials group, gives Amaero a contracted baseline of powder sales over the next financial year, with scope for the customer to lift volumes through additional purchase orders. Importantly, the customer has indicated FY2027 orders are expected to exceed the minimum commitment, pointing to potential upside beyond the initial A$7.8 million. Chairman and CEO Hank Holland said the contract reflects strong commercial activity across Amaero’s business and provides greater bookings and revenue visibility heading into FY2027. “Commercial activity across both segments of Amaero’s business is strong. We are excited to secure a contract for titanium powder shipments in FY2027 that approximates total titanium powder sales in FY2026. We have been advancing numerous titanium powder opportunities over the past 6-12 months with several opportunities potentially exceeding 100 tonnes of annual demand. We are also advancing a strategic contract for refractory powder development that we expect to finalise by the end of the fiscal year. Finally, strong momentum in PM- HIP manufacturing and notable progress toward production contracts continues. We are excited to finish FY2026 with strong performance and expect to enter FY2027 with strong bookings and revenue visibility.” Material terms: Order supports production growth and revenue visibility Strategically, the order underpins Amaero’s plan to lift titanium powder production in FY2027 by about 100% over FY2026, helping match expanding output with committed demand. Management said the contract alone is roughly equivalent to the company’s total titanium powder sales in FY2026, marking a step-up in commercial scale as Amaero builds out its US domestic powder manufacturing footprint. The deal also fits broader market momentum for additive manufacturing materials, with demand being driven by increased 3D printing equipment installations and stronger uptake across defense, aerospace, medical and consumer applications. Amaero said its recently commissioned atomiser capacity positions it to respond to that growth with larger-scale, lower-cost domestic production. View Comments
Amaero lands A$7.8 million titanium powder deal to bolster FY2027 strategy
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...